News

Read our latest news

MgShell wins the first prize of the GoBeyond competition promoted by Sisal

Milan, Italy (December 12, 2023)

Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery platform capable of reshaping patient care and enhancing treatment adherence for patients suffering from retinal diseases, announced its winning of the GoBeyond competition promoted by Sisal.

The advisory journey with one the GoBeyond partners and the equity-free contribution of €50,000 provided by Sisal will facilitate the enhancement of the project’s social impact by funding specific activities aimed at validating new unmet clinical needs and applications. This aligns with the company’s development plan. Here some of the most important news:

 

About MgShell:

MgShell, headquartered in Milan, Italy, is a preclinical-stage drug delivery company focused on developing a magnesium-based drug delivery platform capable of reshaping patient care, enhancing treatment adherence for patients suffering from retinal diseases, and lowering healthcare expenses.

Share this post:

Sign up to our newsletter

Sign up to receive news and information about our products.